Navigation Links
Nylon Finger Traps for Traction

ProductsNylon Finger Traps for Traction
Company Instrument Specialists, Inc.
Item Nylon Finger Traps for Traction
Features 
  • Gentle on the patients skin with a firm grip
    • Description Nylon Finger Traps for optimum patient comfort. The Nylon Finger Trap are gentle on the patients skin with a firm grip. ISI Nylon Finger Traps create a complete upper extremity complete traction system when used with the ISI Digi Grip or ISI Advanced Universal K Table.

    Nylon Finger Traps are available in non-sterile packs and come in five sizes: Extra-small, small, medium, large, and extra-large. Nylon Finger Traps may be purchased individually, in packages of five, or in pre-packaged sets.

    Info Instrument Specialists, Inc.
    Customer Service: (800) 537-1945
    Web site: http://www.isisurgery.com/

    Related medicine products :

    1. Suprafoil Smooth Nylon Foil
    2. Suprafoil Pre-Punched Nylon Foil
    3. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-CAB-ERB
    4. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q51-R-CAB-ERB
    5. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-R-CAB-ERB
    6. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB
    7. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-R-CAB-ERB
    8. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q52-R-CAB-ERB
    9. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q43-CAB-ERB
    10. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q73-CAB-ERB
    11. BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q53-R-CAB-ERB
    Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
    Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 1Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 2National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 1National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 2National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 3Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 1Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 2Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 3